Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Short-term Investments (2018 - 2019)

Usana Health Sciences (USNA) has disclosed Short-term Investments for 4 consecutive years, with $3.0 million as the latest value for Q2 2019.

  • On a quarterly basis, Short-term Investments fell 92.93% to $3.0 million in Q2 2019 year-over-year; TTM through Jun 2019 was $3.0 million, a 92.93% decrease, with the full-year FY2018 number at $63.5 million, changed N/A from a year prior.
  • Short-term Investments was $3.0 million for Q2 2019 at Usana Health Sciences, down from $26.9 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $81.7 million in Q3 2018 to a low of $3.0 million in Q2 2019.